Pharmacovigilance Risk Assessment Committee (PRAC) and their Importance
Introduction EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring the safety of human medicines. It constitutes experts in medicines safety from regulatory authorities in Member States, scientific experts and representatives of patients and healthcare professionals, which are nominated by the European Commission. EMA supports the PRAC by providing data from clinical practice available in electronic …
Pharmacovigilance Risk Assessment Committee (PRAC) and their Importance Read More »